Institution: AMC (Academic Medical Center), Amsterdam
Team: Immuno-hematology group AMC, PI Eric Eldering.
Objectives: Understand and be able to influence metabolic changes induced by malignant cells that subvert T cell function.
Summary: Malignant cells alter the metabolic state and function of surrounding normal T cells. The candidate will investigate this in various B cell malignancies (FL, DLBCL, MM). Healthy donor T cells and patient T cells will be compared for metabolic parameters and in immune function, using cutting edge techniques and co-culture assays (Sea-horse metabolic analyser, metabolomics, candidate gene and drug screens)
As part of our MSCA-ESR training on complementary skills we got to leave the wet lab to explore what happens on the other side of the bench and to learn what it means to be a scientific editor. This is our story.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766214.
Bellvitge Biomedical
Research Institute (IDIBELL)
Hospital Duran i Reynals, 3a planta
Gran Via de l’Hospitalet, 199
08908 L’Hospitalet del Llobregat
Barcelona, Spain
